Atlas Trials

Nitazoxanide Plus Lactulose Versus Lactulose Alone Treatment of Hepatic Encephalopathy

Clinical trial NCT02464124 · UNKNOWN

Trial details

NCT number
NCT02464124
Sponsor
Sherief Abd-Elsalam
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Encephalopathy, Hepatic
Start date
2016-01-01
Primary completion
2017-12-01
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.